Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132928) titled 'Comparison of the application of tegretol and sufentanil in combination with propofol for daytime hysteroscopy examination' on Sept. 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The People's Hospital of Suzhou New District
Condition:
Gynecological diseases require hysteroscopy examination.
Intervention:
Tegileridine:Tegileridine, 20 µg/kg, intravenous injection
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-21
Target Sample Size: Tegileridine:132;sufentanil:132;
Countries of Recruitment:
China
To know more, visit https://www.chi...